Osteoporosis in the elderly: practical approach to prevention and treatment

被引:0
作者
Daragon, A [1 ]
Vittecoq, O [1 ]
机构
[1] CHU Rouen, Hop Bois Guillaume, Serv Rhumatol, F-76031 Rouen, France
来源
PRESSE MEDICALE | 2001年 / 30卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A major public health issue: Osteoporosis in the elderly limits independence and quality of life. Preventive and curative treatment should be adapted to the patient's age. Therapeutic objectives: The goal of preventive like curative treatment is to reduce the risk of fracture. Risk can best be assessed from personal history of fracture or with bone densitometry. Therapeutic methods: Non-drug methods are based on physical activity diet reduction of alcohol intake or smoking, and limiting the risk of fails. Drugs used include calcium, vitamin D, hormone replacement therapy and bisphosphonates. Therapeutic strategy: Prevention programs should focus first on non-drug methods, adapted to the patient's age. For drug regimens, hormone replacement therapy is rarely used after 70 years of age while calcium and vitamin D are widely used. Drugs inhibiting bone resorption, e.g. bisphosphonates, are added on for curative treatment. After the age of 80 years, the calcium vitamin D combination atone is useful. Follow-up: A simple surveillance scheme should include a check-up of renal function every year in patients taking bisphosphonates. it is most difficult to assess treatment efficacy on an individual basis. (C) 2001, Masson, Paris.
引用
收藏
页码:317 / 320
页数:4
相关论文
共 17 条
[1]  
ATTALI G, 1987, RHUMATOLOGIE, V17, P61
[2]  
AZRIA M, 1989, CALCITONINS PHYSL PH, P67
[3]  
Baudoin C, 1995, Rev Prat, V45, P1089
[4]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[5]   VITAMIN-D(3) AND CALCIUM TO PREVENT HIP-FRACTURES IN ELDERLY WOMEN [J].
CHAPUY, MC ;
ARLOT, ME ;
DUBOEUF, F ;
BRUN, J ;
CROUZET, B ;
ARNAUD, S ;
DELMAS, PD ;
MEUNIER, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) :1637-1642
[6]  
CHRISTIANSEN C, 1991, AM J MED, V90, P107
[7]   Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].
Ettinger, B ;
Black, DM ;
Mitlak, BH ;
Knickerbocker, RK ;
Nickelsen, T ;
Genant, HK ;
Christiansen, C ;
Delmas, PD ;
Zanchetta, JR ;
Stakkestad, J ;
Glüer, CC ;
Krueger, K ;
Cohen, FJ ;
Eckert, S ;
Ensrud, KE ;
Avioli, LV ;
Lips, P ;
Cummings, SR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645
[8]  
FARDELLONE P, 1991, REV RHUM, V58, P99
[9]   Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability [J].
Hannon, R ;
Blumsohn, A ;
Naylor, K ;
Eastell, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (07) :1124-1133
[10]   Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial [J].
Harris, ST ;
Watts, NB ;
Genant, HK ;
McKeever, CD ;
Hangartner, T ;
Keller, M ;
Chesnut, CH ;
Brown, J ;
Eriksen, EF ;
Hoseyni, MS ;
Axelrod, DW ;
Miller, PD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14) :1344-1352